Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
General Info
Time period covered
January, 2020 - December, 2020
Data type
Scientific literature
Keywords
Citation
Journal
Lancet Reg Health West Pac
Pages
100041
Publication year
2020
Suggested citation
Ho HL, Wang FY, Lee HR, Huang YL, Lai CL, Jen WC, Hsieh SL, Chou TY. Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients. Lancet Reg Health West Pac. 2020; 3: 100041.